Bonita David P — SEC insider filings

SEC reporting owner CIK 1572451. 55 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers the 50 most recent of 55 filings on record, filed 2021-04-14 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
WINDWARD BIO GROUP AG (WWB)Director, 10% owner31 leg · 1,176,471 sh · $20,000,007—8
IMARA Inc. (IMRA)Director, 10% owner42 legs · 3,333,332 sh · $19,999,992—2
Prelude Therapeutics Inc (PRLD)Director, 10% owner83 legs · 3,684,880 sh · $17,499,997—6
Acutus Medical, Inc. (AFIB)Director42 legs · 1,071,428 sh · $14,999,992—6
ImageneBio, Inc. (IMA)Director117 legs · 759,236 sh · $10,402,390—27
Third Harmonic Bio, Inc. (THRD)Director61 leg · 300,000 sh · $5,100,000—11
Repare Therapeutics Inc. (RPTX)Director10—30 legs · 122,892 sh · $4,189,9394
Tricida, Inc. (TCDA)Director, 10% owner4—3 legs · 10,280,947 sh · $2,205,6355

Insider filings — Bonita David P

FiledFormIssuerReported transactionsSource
2026-11-184WINDWARD BIO GROUP AG (WWB)Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 moreEDGAR
2026-11-164WINDWARD BIO GROUP AG (WWB)Grant/award (A): 22,675 (derivative) @ $0EDGAR
2026-11-123WINDWARD BIO GROUP AG (WWB)Holdings only — no transactions reportedEDGAR
2026-06-184ImageneBio, Inc. (IMA)Grant/award (A): 15,600 (derivative) @ $0EDGAR
2026-06-104Prelude Therapeutics Inc (PRLD)Grant/award (A): 38,000 (derivative) @ $0EDGAR
2026-04-234Prelude Therapeutics Inc (PRLD)Purchase (P): 1,689,189 @ $4.44 · Purchase (P): 1,126,126 @ $4.44EDGAR
2026-04-164ImageneBio, Inc. (IMA)Purchase (P): 336,603 (derivative) · Purchase (P): 384,689 (derivative)EDGAR
2025-08-144Third Harmonic Bio, Inc. (THRD)Other (J): 5,779,071 · Other (J): 43,584 (derivative) @ $0EDGAR
2025-07-304ImageneBio, Inc. (IMA)Option exercise (M): 379 · Purchase (P): 83,611 @ $29.90 · Option exercise (M): 17,520 (derivative) @ $0EDGAR
2025-06-134Prelude Therapeutics Inc (PRLD)Grant/award (A): 38,000 (derivative) @ $0EDGAR
2024-06-204Repare Therapeutics Inc. (RPTX)Grant/award (A): 27,200 (derivative) @ $0EDGAR
2024-06-184Prelude Therapeutics Inc (PRLD)Grant/award (A): 23,500 (derivative) @ $0EDGAR
2024-06-104Ikena Oncology, Inc. (IKNA)Grant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Third Harmonic Bio, Inc. (THRD)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-09-214/AIkena Oncology, Inc. (IKNA)Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-09-144Ikena Oncology, Inc. (IKNA)Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-06-214Prelude Therapeutics Inc (PRLD)Grant/award (A): 23,500 (derivative) @ $0EDGAR
2023-06-154Acutus Medical, Inc. (AFIB)Grant/award (A): 8,400 @ $0 · Grant/award (A): 19,600 (derivative) @ $0EDGAR
2023-06-134Ikena Oncology, Inc. (IKNA)Grant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-124Repare Therapeutics Inc. (RPTX)Grant/award (A): 27,200 (derivative) @ $0EDGAR
2023-06-084Third Harmonic Bio, Inc. (THRD)Grant/award (A): 16,250 (derivative) @ $0EDGAR
2023-05-244Prelude Therapeutics Inc (PRLD)Purchase (P): 869,565 @ $5.75EDGAR
2023-03-084Third Harmonic Bio, Inc. (THRD)Disposition to issuer (D): 13,667 (derivative) · Grant/award (A): 13,667 (derivative)EDGAR
2022-11-254Tricida, Inc. (TCDA)Sale (S): 1,034,421 @ $0.22 · Sale (S): 5,617,300 @ $0.21 · Sale (S): 3,629,226 @ $0.22EDGAR
2022-10-274Third Harmonic Bio, Inc. (THRD)Grant/award (A): 13,667 (derivative) @ $0EDGAR
2022-09-214Third Harmonic Bio, Inc. (THRD)Conversion (C): 5,479,071 · Purchase (P): 300,000 @ $17 · Conversion (C): 8,593,750 (derivative) · Conversion (C): 2,441,407 (derivative) · Conversion (C): 1,342,065 (derivative)EDGAR
2022-06-244Ikena Oncology, Inc. (IKNA)Purchase (P): 66,806 @ $3.55 · Purchase (P): 23,419 @ $3.71 · Purchase (P): 65,965 @ $4.37 · Purchase (P): 96,035 @ $5.37EDGAR
2022-06-224Prelude Therapeutics Inc (PRLD)Grant/award (A): 34,300 (derivative) @ $0EDGAR
2022-06-214Acutus Medical, Inc. (AFIB)Grant/award (A): 8,400 @ $0 · Grant/award (A): 19,600 (derivative) @ $0EDGAR
2022-06-164Tricida, Inc. (TCDA)Grant/award (A): 27,207 (derivative) @ $0EDGAR
2022-06-134Ikena Oncology, Inc. (IKNA)Grant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-034IMARA Inc. (IMRA)Grant/award (A): 8,500 (derivative) @ $0EDGAR
2022-05-164Repare Therapeutics Inc. (RPTX)Grant/award (A): 49,000 (derivative) @ $0EDGAR
2021-12-234Ikena Oncology, Inc. (IKNA)Grant/award (A): 13,419 (derivative) @ $0EDGAR
2021-11-174Tricida, Inc. (TCDA)Grant/award (A): 666,667 @ $6 · Grant/award (A): 666,667 (derivative)EDGAR
2021-09-084Repare Therapeutics Inc. (RPTX)Sale (S): 6,985 @ $34 · Sale (S): 212 @ $34 · Sale (S): 861 @ $33.93 · Sale (S): 26 @ $33.93EDGAR
2021-09-024Repare Therapeutics Inc. (RPTX)Sale (S): 8,223 @ $33.94 · Sale (S): 249 @ $33.94 · Sale (S): 12,586 @ $33.98 · Sale (S): 382 @ $33.98 · Sale (S): 15,941 @ $34.24 · Sale (S): 483 @ $34.24EDGAR
2021-08-304Repare Therapeutics Inc. (RPTX)Sale (S): 4,157 @ $34.52 · Sale (S): 126 @ $34.52 · Sale (S): 6,884 @ $33.94 · Sale (S): 209 @ $33.94 · Sale (S): 6,500 @ $33.92 · Sale (S): 197 @ $33.92EDGAR
2021-08-254Repare Therapeutics Inc. (RPTX)Sale (S): 16,886 @ $34.12 · Sale (S): 512 @ $34.12 · Sale (S): 2,852 @ $33.99 · Sale (S): 78 @ $33.99EDGAR
2021-08-254Repare Therapeutics Inc. (RPTX)Sale (S): 6,885 @ $34.06 · Sale (S): 209 @ $34.06 · Sale (S): 3,920 @ $34.07 · Sale (S): 119 @ $34.07 · Sale (S): 6,874 @ $34.34 · Sale (S): 208 @ $34.34EDGAR
2021-08-194Repare Therapeutics Inc. (RPTX)Sale (S): 16,886 @ $34.12 · Sale (S): 512 @ $34.12 · Sale (S): 2,852 @ $33.99 · Sale (S): 78 @ $33.99EDGAR
2021-07-234/AIMARA Inc. (IMRA)Purchase (P): 1,666,666 @ $6EDGAR
2021-07-214Acutus Medical, Inc. (AFIB)Purchase (P): 714,285 @ $14 · Purchase (P): 357,143 @ $14EDGAR
2021-07-164IMARA Inc. (IMRA)Purchase (P): 1,666,666 @ $6EDGAR
2021-06-304IMARA Inc. (IMRA)Grant/award (A): 7,728 (derivative) @ $0EDGAR
2021-06-224Acutus Medical, Inc. (AFIB)Grant/award (A): 1,800 @ $0 · Grant/award (A): 7,022 (derivative) @ $0EDGAR
2021-06-224Prelude Therapeutics Inc (PRLD)Grant/award (A): 23,344 (derivative) @ $0EDGAR
2021-06-114Tricida, Inc. (TCDA)Grant/award (A): 16,403 @ $0 · Grant/award (A): 57,235 (derivative) @ $0EDGAR
2021-05-144Repare Therapeutics Inc. (RPTX)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2021-04-144/AIkena Oncology, Inc. (IKNA)Conversion (C): 1,470,872 · Conversion (C): 42,614 · Purchase (P): 375,000 @ $16 · Purchase (P): 48,400 @ $16 · Conversion (C): 5,429,023 · Conversion (C): 157,288 · +10 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1572451 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs